Trials / Terminated
TerminatedNCT01972061
Foot/Hand Neuromodulation for Overactive Bladder (OAB)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Christopher J Chermansky, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if electrical stimulation of the foot is effective in the treatment of overactive bladder conditions.
Detailed description
Foot neuromodulation is designed to treat OAB conditions by electrically stimulating the somatic afferent nerves in the foot using skin surface electrodes. The foot stimulation is non-invasive, can be performed at home, and has no adverse effects. Foot neuromodulation therapy will likely be accepted by more patients and have the potential to make a broader impact on the improvement of OAB conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Foot stimulation | Foot stimulation electrically activates the somatic afferent nerves in the foot using FDA-approved, commercially available transcutaneous electrical nerve stimulator (TENS) and skin surface electrodes attached to the foot. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2018-12-11
- Completion
- 2018-12-11
- First posted
- 2013-10-30
- Last updated
- 2020-02-26
- Results posted
- 2020-02-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01972061. Inclusion in this directory is not an endorsement.